BillionToOne valued at $4.4 billion as shares surge in blockbuster Nasdaq debut
Shares of BillionToOne rose 66.67% in their Nasdaq debut on Thursday, valuing the molecular diagnostics firm at $4.4 billion. ...
Shares of BillionToOne rose 66.67% in their Nasdaq debut on Thursday, valuing the molecular diagnostics firm at $4.4 billion. ...